ORBIMED ADVISORS LLC

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
329 26% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -30%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
ORBIMED ADVISORS LLC's trades of Scribe Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27
B Purchase
90,866 +43.6%
29.25
US$4,479,581 		90,866 +43.6% 29.25 US$4,479,581
2026-07-09 2026-07-07
PlS Planned sale
98,452 +49.2%
470.68
US$1,729,996 		98,452 +49.2% 470.68 US$1,729,996
2026-07-02 2026-06-30
PlS Planned sale
11,347 +15.1%
192.21
US$4,461,964 		11,347 +15.1% 192.21 US$4,461,964
2026-06-24 2026-06-22
S Sale
46,776 -0.7%
45.00
US$2,104,920 		46,776 -0.7% 45.00 US$2,104,920
2026-06-24 2026-06-22
S Sale
787,024 -10.7%
45.38
US$35,715,149 		787,024 -10.7% 45.38 US$35,715,149
2026-06-24 2026-06-22
S Sale
1,477 -0.7%
45.00
US$66,465 		1,477 -0.7% 45.00 US$66,465
2026-06-24 2026-06-22
S Sale
24,846 -10.1%
45.38
US$1,127,511 		24,846 -10.1% 45.38 US$1,127,511
2026-06-22 2026-06-22
PrS Proposed sale
1,477
45.96
US$67,883 		1,477 45.96 US$67,883
2026-06-22 2026-06-22
PrS Proposed sale
1,477
45.96
US$67,883 		1,477 45.96 US$67,883
2026-06-22 2026-06-22
PrS Proposed sale
24,846
45.96
US$1,141,922 		24,846 45.96 US$1,141,922
2026-06-22 2026-06-22
PrS Proposed sale
24,846
45.96
US$1,141,922 		24,846 45.96 US$1,141,922
2026-06-22 2026-06-22
PrS Proposed sale
46,776
45.96
US$2,149,825 		46,776 45.96 US$2,149,825
2026-06-22 2026-06-22
PrS Proposed sale
46,776
45.96
US$2,149,825 		46,776 45.96 US$2,149,825
2026-06-22 2026-06-22
PrS Proposed sale
787,024
45.96
US$36,171,623 		787,024 45.96 US$36,171,623
2026-06-22 2026-06-22
PrS Proposed sale
787,024
45.96
US$36,171,623 		787,024 45.96 US$36,171,623
2026-06-17 2026-06-15
S Sale
272,322 -3.6%
45.02
US$12,259,936 		272,322 -3.6% 45.02 US$12,259,936
2026-06-17 2026-06-15
S Sale
9,086 -3.6%
45.02
US$409,052 		9,086 -3.6% 45.02 US$409,052
2026-06-15 2026-06-15
PrS Proposed sale
272,322
42.36
US$11,535,560 		272,322 42.36 US$11,535,560
2026-06-15 2026-06-15
PrS Proposed sale
9,086
42.36
US$384,883 		9,086 42.36 US$384,883
2026-06-01 2026-05-29
PrS Proposed sale
210,876
42.82
US$9,029,710 		210,876 42.82 US$9,029,710
2026-05-29 2026-05-29
PrS Proposed sale
1,082,480
42.80
US$46,330,144 		1,082,480 42.80 US$46,330,144
2026-06-01 2026-05-28
US Q32 Bio Inc (QTTB)
B Purchase
625,000 +inf%
8.00
US$5,000,000 		625,000 +inf% 8.00 US$5,000,000
2026-06-01 2026-05-28
US Q32 Bio Inc (QTTB)
B Purchase
1,250,000 +55.5%
8.00
US$10,000,000 		1,250,000 +55.5% 8.00 US$10,000,000
2026-05-29 2026-05-27
PlS Planned sale
101 -0.0%
44.49
US$4,493 		101 -0.0% 44.49 US$4,493
2026-05-11 2026-05-11
PlS Planned sale
184,639 -6.5%
46.22
US$8,534,015 		184,639 -6.5% 46.22 US$8,534,015
2026-05-11 2026-05-08
PlS Planned sale
59,767 -2.0%
44.58
US$2,664,413 		59,767 -2.0% 44.58 US$2,664,413
2026-05-11 2026-05-07
PlS Planned sale
48,546 -1.6%
44.61
US$2,165,637 		48,546 -1.6% 44.61 US$2,165,637
2026-04-23 2026-04-21
B Purchase
1,126,126 +inf%
4.44
US$4,999,999 		1,126,126 +inf% 4.44 US$4,999,999
2026-04-23 2026-04-21
B Purchase
1,689,189 +16.7%
4.44
US$7,499,999 		1,689,189 +16.7% 4.44 US$7,499,999
2026-04-21 2026-04-18
PlS Planned sale
2,948 -0.1%
44.52
US$131,245 		2,948 -0.1% 44.52 US$131,245
2026-04-21 2026-04-17
PlS Planned sale
52,397 -1.7%
44.68
US$2,341,098 		52,397 -1.7% 44.68 US$2,341,098
2026-04-28 2026-04-16
B Purchase
597,729 +98.7%
1.67
US$998,207 		597,729 +98.7% 1.67 US$998,207
2026-04-16 2026-04-16
PlS Planned sale
226,906 -7.0%
45.34
US$10,287,918 		226,906 -7.0% 45.34 US$10,287,918
2026-04-16 2026-04-15
PlS Planned sale
235,863 -6.8%
44.64
US$10,528,924 		235,863 -6.8% 44.64 US$10,528,924
2026-04-16 2026-04-14
PlS Planned sale
47,814 -1.4%
44.51
US$2,128,201 		47,814 -1.4% 44.51 US$2,128,201
2026-04-09 2026-04-09
PrS Proposed sale
78,499
6.55
US$514,168 		78,499 6.55 US$514,168
2026-04-09 2026-04-08
S Sale
40,416 -100.0%
6.52
US$263,512 		40,416 -100.0% 6.52 US$263,512
2026-04-09 2026-04-08
S Sale
32,523 -100.0%
6.29
US$204,570 		32,523 -100.0% 6.29 US$204,570
2026-04-09 2026-04-07
S Sale
2,400 -6.9%
6.38
US$15,312 		2,400 -6.9% 6.38 US$15,312
2026-04-09 2026-04-07
S Sale
29,319 -45.6%
6.53
US$191,453 		29,319 -45.6% 6.53 US$191,453
2026-03-31 2026-03-31
PrS Proposed sale
45,057
11.04
US$497,429 		45,057 11.04 US$497,429
2026-02-04 2026-02-03
S Sale
29,063 -0.8%
44.58
US$1,295,629 		29,063 -0.8% 44.58 US$1,295,629
2026-02-04 2026-02-03
S Sale
29,063 -0.8%
44.58
US$1,295,629 		29,063 -0.8% 44.58 US$1,295,629
2026-02-04 2026-02-02
S Sale
1,890 -0.1%
44.57
US$84,237 		1,890 -0.1% 44.57 US$84,237
2025-12-29 2025-12-24
S Sale
33,356 -0.9%
44.55
US$1,486,010 		33,356 -0.9% 44.55 US$1,486,010